Issue Date: August 23, 2010
Taking The Measure Of The New Agilent
Scientific instrument maker Agilent finally completed the $1.5 billion acquisition of competitor Varian in May. This pivotal deal, intended to bolster Agilent’s life sciences and chemical analysis businesses, took a full 10 months to complete. William P. (Bill) Sullivan, Agilent’s chief executive officer, is glad the deal is finally done. And he says other deals, both large and small, could come in the future.
But for now, Sullivan says, “we are focusing on . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society